1,145 research outputs found
Coronary side-effect potential of current and prospective antimigraine drugs
BACKGROUND: The antimigraine drugs ergotamine and sumatriptan may cause
angina-like symptoms, possibly resulting from coronary artery
constriction. We compared the coronary vasoconstrictor potential of a
number of current and prospective antimigraine drugs (ergotamine,
dihydroergotamine, methysergide and its metabolite methylergometrine,
sumatriptan, naratriptan, zolmitriptan, rizatriptan, avitriptan). METHODS
AND RESULTS: Concentration-response curves to the antimigraine drugs were
constructed in human isolated coronary artery segments to obtain the
maximum contractile response (Emax) and the concentration eliciting 50% of
Emax (EC50). The EC50 values were related to maximum plasma concentrations
(Cmax) reported in patients, obtaining Cmax/EC50 ratios as an index of
coronary vasoconstriction occurring in the clinical setting. Furthermore,
we studied the duration of contractile responses after washout of the
acutely acting antimigraine drugs to assess their disappearance from the
recept
Headache in people with epilepsy
Epidemiological estimates indicate that individuals with epilepsy are more likely to experience headaches, including migraine, than individuals without epilepsy. Headaches can be temporally unrelated to seizures, or can occur before, during or after an episode; seizures and migraine attacks are mostly not temporally linked. The pathophysiological links between headaches (including migraine) and epilepsy are complex and have not yet been fully elucidated. Correct diagnoses and appropriate treatment of headaches in individuals with epilepsy is essential, as headaches can contribute substantially to disease burden. Here, we review the insights that have been made into the associations between headache and epilepsy over the past 5 years, including information on the pathophysiological mechanisms and genetic variants that link the two disorders. We also discuss the current best practice for the management of headaches co-occurring with epilepsy and highlight future challenges for this area of research.Paroxysmal Cerebral Disorder
Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation
Crossover to the KPZ equation
We characterize the crossover regime to the KPZ equation for a class of
one-dimensional weakly asymmetric exclusion processes. The crossover depends on
the strength asymmetry () and it occurs at
. We show that the density field is a solution of an
Ornstein-Uhlenbeck equation if , while for it is
an energy solution of the KPZ equation. The corresponding crossover for the
current of particles is readily obtained.Comment: Published by Annales Henri Poincare Volume 13, Number 4 (2012),
813-82
Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without
Background and purpose This study was undertaken to investigate migraine prevalence in persons with hallucinogen persisting perception disorder (HPPD) presenting as visual snow syndrome (VSS).Methods Persons with visual snow as a persisting symptom after illicit drug use (HPPD) were recruited via a Dutch consulting clinic for recreational drug use. A structured interview on (visual) perceptual symptomatology, details of drugs use, and medical and headache history was taken. As a control group, persons with visual snow who had never used illicit drugs prior to onset were included. The primary outcome was lifetime prevalence of migraine. Symptom severity was evaluated by the Visual Snow Handicap Inventory (VHI), a 25-item questionnaire.Results None of the 24 HPPD participants had migraine, whereas 20 of 37 (54.1%) controls had migraine (p < 0.001). VHI scores did not differ significantly between the two groups; in both groups, the median score was 38 of 100. In most HPPD cases (17/24, 70.9%), visual snow had started after intake of ecstasy; other psychedelic drugs reported included cannabis, psilocybin mushrooms, amphetamine, 4-fluoroamphetamine, 3-methylmethcathinone, 4-Bromo-2,5-dimethoxypenethylamine, and nitrous oxide.Conclusions Whereas none of the HPPD participants had migraine, more than half of the visual snow controls without prior use of illicit drugs had migraine. This suggests that at least partly different pathophysiological factors play a role in these disorders. Users of ecstasy and other hallucinogens should be warned of the risk of visual snow. Further studies are needed to enhance understanding of the underlying neurobiology of HPPD and VSS to enable better management of these conditions.Paroxysmal Cerebral Disorder
Sample-size dependence of the ground-state energy in a one-dimensional localization problem
We study the sample-size dependence of the ground-state energy in a
one-dimensional localization problem, based on a supersymmetric quantum
mechanical Hamiltonian with random Gaussian potential. We determine, in the
form of bounds, the precise form of this dependence and show that the
disorder-average ground-state energy decreases with an increase of the size
of the sample as a stretched-exponential function, , where the
characteristic exponent depends merely on the nature of correlations in the
random potential. In the particular case where the potential is distributed as
a Gaussian white noise we prove that . We also predict the value of
in the general case of Gaussian random potentials with correlations.Comment: 30 pages and 4 figures (not included). The figures are available upon
reques
Time lost due to an attack: a novel patient-reported outcome measure for acute migraine treatments
Objective We propose a new outcome measure to assess the efficacy of migraine treatments translating the approach of the Global Burden of Disease studies from a societal to an individual level: Instead of calculating "years lived with disability", we suggest estimating "time lost due to an attack".MethodsTime lost due to an attack is calculated by multiplying the duration and the degree of impaired functioning during an attack.ResultsTime lost due to an attack, different from other outcome measures, does not just focus on the short-term analgesic effects of treatments, but rather on the improvement of all migraine symptoms and restoration of functioning, also considering therapy-related impairment. Importantly, time lost due to an attack measures the entire time patients are not functioning normally, from onset to complete resolution.ConclusionsTime lost due to an attack represents a new paradigm to assess migraine burden in single patients for a patient-centered evaluation of both acute and prophylactic treatments.Paroxysmal Cerebral Disorder
Hypothalamic functional MRI activity in the initiation phase of spontaneous and glyceryl trinitrate-induced migraine attacks
The hypothalamus has been suggested to be important in the initiation cascade of migraine attacks based on clinical and biochemical observations. Previous imaging studies could not disentangle the changes due to the attack and those due to the trigger compound. With a novel approach, we assessed hypothalamic neuronal activity in early premonitory phases of glyceryl-trinitrate (GTN)-induced and spontaneous migraine attacks. We measured the hypothalamic blood oxygen level-dependent (BOLD) response to oral glucose ingestion with 3T-functional magnetic resonance imaging (MRI) in 27 women, 16 with migraine without aura and 11 controls group matched for age and body mass index (BMI), on 1 day without prior GTN administration and on a second day after GTN administration (to coincide with the premonitory phase of an induced attack). Interestingly, subgroups of patients with and without GTN-triggered attacks could be compared. Additionally, five migraineurs were investigated in a spontaneous premonitory phase. Linear mixed models were used to study between- and within-group effects. Without prior GTN infusion, the BOLD response to glucose was similar in migraine participants and controls (P = .41). After prior GTN infusion, recovery occurred steeper and faster in migraineurs (versus Day 1; P < .0001) and in those who developed an attack versus those who did not (P < .0001). Prior GTN infusion did not alter the glucose-induced response in controls (versus baseline; P = .71). Just before spontaneous attacks, the BOLD-response recovery was also faster (P < .0001). In this study, we found new and direct evidence of altered hypothalamic neuronal function in the immediate preclinical phase of both GTN-provoked and spontaneous migraine attacks.Neuro Imaging Researc
- …